Revenue | ₹1,029.75Cr |
Net Profits | ₹65.18Cr |
Net Profit Margins | 6.33% |
Akums Drugs & Pharmaceuticals Ltd’s revenue fell -5.76% since last year same period to ₹1,029.75Cr in the Q3 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -1.95% fall in its revenue since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit fell -66.35% since last year same period to ₹65.18Cr in the Q3 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -0.05% fall in its net profits since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit margin fell -64.29% since last year same period to 6.33% in the Q3 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 1.94% jump in its net profit margins since last 3-months.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹1,029.75Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹65.18Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was 6.33%.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹1,092.67Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹193.70Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was 17.73%.